Literature DB >> 11572418

Smoking in urban African Americans: behaviors, gender differences, and motivation to quit.

M N Woods1, K J Harris, J S Ahluwalia, K H Schmelzle, M S Mayo.   

Abstract

OBJECTIVE: This study describes smoking behaviors and gender differences, and correlates these factors with motivation to quit smoking among African-American smokers at a community-based health center.
DESIGN: A 62-item survey assessed depression, hassles, readiness to change, and demographics.
METHODS: Participants (N = 81) were interviewed in an adult clinic waiting room.
RESULTS: On average, participants smoked 13 cigarettes per day. Many reported attempts to reduce smoking-related health risks: 46% switched brands, 57% reduced their smoking, and 19% smoked only on some days. Fifty-nine percent indicated depressive symptoms. For women vs men, noteworthy differences were: reduction in number of cigarettes smoked (66.7% vs 40.0%; P = .023), switching brands (58.8% vs 23.3%; P = .003), number of attempts to quit in the past year (2.7 vs 1.2; P = .034), and high concern about weight gain (52.9% vs 26.7%; P = .047). Cigarettes smoked per day was negatively correlated with motivation to quit (P = .022). Variables positively correlated with motivation to quit included: harm reduction strategies (P = .002), intention to quit in 30 days (P<.0001), and intention to quit in 6 months (P<.0001).
CONCLUSIONS: Women showed more potential indications of readiness to quit, including more attempts to quit, reductions in number of cigarette smoked, and brand switching. Knowledge of cessation barriers, gender differences, and correlates to motivation may prove useful for investigators conducting research in this population.

Entities:  

Mesh:

Year:  2001        PMID: 11572418

Source DB:  PubMed          Journal:  Ethn Dis        ISSN: 1049-510X            Impact factor:   1.847


  8 in total

1.  Participation of African Americans in a smoking cessation trial: a quantitative and qualitative study.

Authors:  Malaika N Woods; Kari Jo Harris; Matthew S Mayo; Delwyn Catley; Monica Scheibmeir; Jasjit S Ahluwalia
Journal:  J Natl Med Assoc       Date:  2002-07       Impact factor: 1.798

2.  Problem recognition, intention to stop use, and treatment use among regular heroin injectors.

Authors:  Rebecca Trenz; Typhanye Penniman; Michael Scherer; Julia Zur; Jonathan Rose; William Latimer
Journal:  J Subst Abuse Treat       Date:  2012-02-01

3.  KLOTHO allele status and the risk of early-onset occult coronary artery disease.

Authors:  Dan E Arking; Diane M Becker; Lisa R Yanek; Daniele Fallin; Daniel P Judge; Taryn F Moy; Lewis C Becker; Harry C Dietz
Journal:  Am J Hum Genet       Date:  2003-03-31       Impact factor: 11.025

4.  Design, recruitment, and retention of African-American smokers in a pharmacokinetic study.

Authors:  Babalola Faseru; Lisa S Cox; Carrie A Bronars; Isaac Opole; Gregory A Reed; Matthew S Mayo; Jasjit S Ahluwalia; Kolawole S Okuyemi
Journal:  BMC Med Res Methodol       Date:  2010-01-19       Impact factor: 4.615

5.  A latent class approach to treatment readiness corresponds to a transtheoretical ("Stages of Change") model.

Authors:  Paul Truman Harrell; R C Trenz; M Scherer; S S Martins; W W Latimer
Journal:  J Subst Abuse Treat       Date:  2013-05-22

Review 6.  Epidemiology, determinants, and consequences of cigarette smoking in African American women: an integrative review.

Authors:  Lavonda Mickens; Katie Ameringer; Molly Brightman; Adam M Leventhal
Journal:  Addict Behav       Date:  2009-12-21       Impact factor: 3.913

7.  Quitting activity and tobacco brand switching: findings from the ITC-4 Country Survey.

Authors:  Genevieve A Cowie; Elena Swift; Timea Partos; Ron Borland
Journal:  Aust N Z J Public Health       Date:  2015-04       Impact factor: 2.939

8.  Determinants of intentions to quit smoking among adult smokers in Bangladesh: findings from the International Tobacco Control (ITC) Bangladesh wave 2 survey.

Authors:  Pete Driezen; Abu S Abdullah; Anne C K Quah; Nigar Nargis; Geoffrey T Fong
Journal:  Glob Health Res Policy       Date:  2016-08-17
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.